Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Control and dysregulation of redox signalling in the gastrointestinal tract
Eric L. Campbell, Sean P. Colgan
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 16, Iss. 2, pp. 106-120
Open Access | Times Cited: 178

Showing 1-25 of 178 citing articles:

Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
Ze Chen, Ruifeng Tian, Zhi‐Gang She, et al.
Free Radical Biology and Medicine (2020) Vol. 152, pp. 116-141
Open Access | Times Cited: 924
Sleep Loss Can Cause Death through Accumulation of Reactive Oxygen Species in the Gut
Alexandra Vaccaro, Yosef Kaplan Dor, Keishi Nambara, et al.
Cell (2020) Vol. 181, Iss. 6, pp. 1307-1328.e15
Open Access | Times Cited: 371
Transportation noise pollution and cardiovascular disease
Thomas Münzel, Mette Sørensen, Andreas Daiber
Nature Reviews Cardiology (2021) Vol. 18, Iss. 9, pp. 619-636
Closed Access | Times Cited: 366
A comparative review of microplastics and nanoplastics: Toxicity hazards on digestive, reproductive and nervous system
Kai Yin, Yu Wang, Hongjing Zhao, et al.
The Science of The Total Environment (2021) Vol. 774, pp. 145758-145758
Closed Access | Times Cited: 295
Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease
Arno R. Bourgonje, Martin Feelisch, Klaas Nico Faber, et al.
Trends in Molecular Medicine (2020) Vol. 26, Iss. 11, pp. 1034-1046
Open Access | Times Cited: 258
Antioxidant Activity of Polyphenolic Plant Extracts
Dimitrios Stagos
Antioxidants (2019) Vol. 9, Iss. 1, pp. 19-19
Open Access | Times Cited: 168
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation
Md. Mominur Rahman, Fahadul Islam, Md. Harun- Or-Rashid, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 151
A Cross-Sectional Study of Compositional and Functional Profiles of Gut Microbiota in Sardinian Centenarians
Lu Wu, Tiansheng Zeng, Angelo Zinellu, et al.
mSystems (2019) Vol. 4, Iss. 4
Open Access | Times Cited: 148
Design of Diselenide-Bridged Hyaluronic Acid Nano-antioxidant for Efficient ROS Scavenging to Relieve Colitis
Jiaqi Xu, Tianjiao Chu, Tingting Yu, et al.
ACS Nano (2022) Vol. 16, Iss. 8, pp. 13037-13048
Closed Access | Times Cited: 138
Dietary Regulation of Oxidative Stress in Chronic Metabolic Diseases
Shuai Jiang, Hui Liu, Chunbao Li
Foods (2021) Vol. 10, Iss. 8, pp. 1854-1854
Open Access | Times Cited: 128
Photoaging enhanced the adverse effects of polyamide microplastics on the growth, intestinal health, and lipid absorption in developing zebrafish
Xingli Zhang, Mengli Xia, Jingyi Zhao, et al.
Environment International (2021) Vol. 158, pp. 106922-106922
Open Access | Times Cited: 107
Harnessing polymer-derived drug delivery systems for combating inflammatory bowel disease
Yuji Pu, Fan Xi, Zhuangzhuang Zhang, et al.
Journal of Controlled Release (2022) Vol. 354, pp. 1-18
Closed Access | Times Cited: 75
Oral Metal‐Free Melanin Nanozymes for Natural and Durable Targeted Treatment of Inflammatory Bowel Disease (IBD)
Qiong Huang, Yuqi Yang, Yan Zhu, et al.
Small (2023) Vol. 19, Iss. 19
Closed Access | Times Cited: 74
Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets
Arno R. Bourgonje, Damian Klóska, Anna Grochot-Przęczek, et al.
Redox Biology (2023) Vol. 60, pp. 102603-102603
Open Access | Times Cited: 60
An Orally-Administered Nanotherapeutics with Carbon Monoxide Supplying for Inflammatory Bowel Disease Therapy by Scavenging Oxidative Stress and Restoring Gut Immune Homeostasis
Xu Zhang, Zhang Yuan, Jianshuang Wu, et al.
ACS Nano (2023) Vol. 17, Iss. 21, pp. 21116-21133
Closed Access | Times Cited: 54
The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease
Sem Geertsema, Arno R. Bourgonje, Raphael R. Fagundes, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 10, pp. 830-842
Open Access | Times Cited: 46
An Engineered Butyrate-Derived Polymer Nanoplatform as a Mucosa-Healing Enhancer Potentiates the Therapeutic Effect of Magnolol in Inflammatory Bowel Disease
Fan Xi, Zhuangzhuang Zhang, Wenxia Gao, et al.
ACS Nano (2023) Vol. 18, Iss. 1, pp. 229-244
Closed Access | Times Cited: 45
Nanozyme‐Based Regulation of Cellular Metabolism and Their Applications
Yue Wang, Xiaodan Jia, Shangjie An, et al.
Advanced Materials (2023) Vol. 36, Iss. 10
Closed Access | Times Cited: 43
Circadian rhythm regulates the function of immune cells and participates in the development of tumors
Yuen Zeng, Zichan Guo, Mengqi Wu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 31
Enzyme-like biomimetic oral-agent enabling modulating gut microbiota and restoring redox homeostasis to treat inflammatory bowel disease
Zhangpeng Shi, Xiaohong Li, Jufeng Chen, et al.
Bioactive Materials (2024) Vol. 35, pp. 167-180
Open Access | Times Cited: 23
The fate of dietary polysaccharides in the digestive tract
Qiao Yang, Songlin Chang, Xinfang Zhang, et al.
Trends in Food Science & Technology (2024) Vol. 150, pp. 104606-104606
Closed Access | Times Cited: 17
Single-Atom-Based Nanoenzyme in Tissue Repair
Ziliang Fu, Kexin Fan, Xingjian He, et al.
ACS Nano (2024) Vol. 18, Iss. 20, pp. 12639-12671
Closed Access | Times Cited: 16
Engineered probiotic ameliorates ulcerative colitis by restoring gut microbiota and redox homeostasis
Peilin Guo, Wenjing Wang, Qian Xiang, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 9, pp. 1502-1518.e9
Closed Access | Times Cited: 16
The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications
Ting Ding, Chang Liu, Zhengyu Li
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Engineered Bacteria for Disease Diagnosis and Treatment Using Synthetic Biology
Kai Jin, Yi Huang, Hailong Che, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top